
Surging Demand! Investors Flock to Senores Pharma IPO.
Senores Pharmaceuticals Enters the Market with Strong Backing Investors have shown remarkable enthusiasm for the Senores Pharmaceuticals IPO, with an impressive 13-fold subscription within the first two days of bidding. The rising interest primarily stemmed from retail and non-institutional investors, while institutional